COVID-19

News

Lilly's antibody therapy cuts hospitalisation rates in COVID...

Eli Lilly has followed up supportive data from its Olumiant in COVID-19 with results of a study showing its antibody treatment could help prevent hospitalisation from the disease.<

News

Coronavirus vaccine: how pharma is picking up the pace

BioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vac...

In May, Germany pledged to provide up to €750 million ($889 million) in funding to support vaccines against COVID-19, and the main recipients have now been revealed – BioNTech, CureVac and

News

Regeneron tests COVID-19 antibody therapy in UK's RECOVERY t...

Regeneron’s COVID-19 antibody cocktail has been added to the UK’s RECOVERY trial, one of the largest of its kind in the world that is testing several potential coronavirus therapies at the

News

Trial backs Lilly’s Olumiant plus remdesivir as combo COVID-...

Adding Eli Lilly’s rheumatoid arthritis drug Olumiant (baricitinib) and Gilead Sciences’ remdesivir reduces recovery time in COVID-19 patients compared to remdesivir alone, says a new trial

News

Eyeing emergency use of COVID-19 drug, Humanigen partners wi...

Humanigen is hoping for emergency use authorisation in the US for an antibody to treat severe COVID-19 before the end of 2020, and has teamed up with Swiss contract manufacturer Lonza to ma

News

London, January 26, 2020. People wearing a face masks to protecting themself because of epidemic in China. Selective Focus. Concept of coronavirus quarantine. MERS-Cov, middle East respiratory syndrome coronavirus, Novel coronavirus 2019-nCoV.

Revised COVID-19 contact-tracing app gets launch date in Eng...

The UK government’s COVID-19 contact-tracing app is to be launched across England and Wales on 24th September, after months of delays while the project had to be completely reworked.

Lilly's antibody therapy cuts hospitalisation rates in COVID...

BioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vac...

Regeneron tests COVID-19 antibody therapy in UK's RECOVERY t...

Trial backs Lilly’s Olumiant plus remdesivir as combo COVID-...

Eyeing emergency use of COVID-19 drug, Humanigen partners wi...

Revised COVID-19 contact-tracing app gets launch date in Eng...

On genomics, NGS, and doing much more good than bad, with Ma...

How to meet your physicians where they are online

COVID-19

Editor's Picks